Legal Representation
Attorney
Michael J. Bevilacqua, Esquire
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 27, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 6, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 5, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 5, 2006 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 5, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 6, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 14, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 22, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 26, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 20, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 19, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 19, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 5, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
reagents for the detection of polymerase chain reactions for scientific or research use; diagnostic kits containing a reagent for the detection of polymerase chain reactions for scientific or research use; chemical products, namely, synthetic oligonucleotides for use in the manufacture of pharmaceuticals for modulating the immune system
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001